Screening compound: C33H39FN2O6S (K784-4353)

Screening compound: C<sub>33</sub>H<sub>39</sub>FN<sub>2</sub>O<sub>6</sub>S (K784-4353)
Screening compound: C<sub>33</sub>H<sub>39</sub>FN<sub>2</sub>O<sub>6</sub>S (K784-4353) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C33H39FN2O6S (K784-4353)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K784-4353

Molecular Formula

C33H39FN2O6S (C33 H39 FN2 O6 S)

Compound Name

ethyl 4-({N-[(4-methoxyphenyl)methyl]3-[(3,4-dimethylphenyl)carbamoyl]-4-fluorobenzenesulfonamido}methyl)cyclohexane-1-carboxylate

IUPAC name

ethyl 4-({N-[(4-methoxyphenyl)methyl]3-[(34-dimethylphenyl)carbamoyl]-4-fluorobenzenesulfonamido}methyl)cyclohexane-1-carboxylate

SMILES

CCOC(C1CCC(CN(Cc(cc2)ccc2OC)S(c(cc2)cc(C(Nc3cc(C)c(C)cc3)=O)c2F)(=O)=O)CC1)=O

InChI

InChI=1S/C33H39FN2O6S/c1-5-42-33(38)26-11-7-24(8-12-26)20-36(21-25-9-14-28(41-4)15-10-25)43(39,40)29-16-17-31(34)30(19-29)32(37)35-27-13-6-22(2)23(3)18-27/h6,9-10,13-19,24,26H,5,7-8,11-12,20-21H2,1-4H3,(H,35,37)

InChI Key

OCKKVLGAULZZJV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15097865

C33H39FN2O6S (K784-4353) in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

3D-Biodiversity Library (27607 compounds)

CNS targets activity set (6557 compounds)

CORONAVIRUS Library (20774 compounds)

Eccentric PPI Library (11937 compounds)

Human GPCR Annotated Library (5539 compounds)

Lipid Metabolism Library (9174 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Selective Target Activity Profiling Library (14702 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cardiovascular
  • Metabolic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Structure:
  • 3D
  • Cyclic compounds
Mechanism of action:
  • PPI modulators
  • PPI modulators

References: we are preparing a list of scientific research reports with C33H39FN2O6S (K784-4353) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C33H39FN2O6S (K784-4353)?
Check Price and Availability of C33H39FN2O6S (K784-4353), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C33H39FN2O6S (K784-4353) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C33H39FN2O6S (K784-4353)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C33H39FN2O6S (K784-4353)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C33H39FN2O6S (K784-4353) available by request